BELLEVICINE, CLAUDIO
 Distribuzione geografica
Continente #
EU - Europa 3.272
NA - Nord America 2.485
AS - Asia 1.967
SA - Sud America 255
AF - Africa 67
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.051
Nazione #
US - Stati Uniti d'America 2.425
RU - Federazione Russa 1.654
SG - Singapore 990
IT - Italia 775
HK - Hong Kong 467
CN - Cina 316
DE - Germania 258
BR - Brasile 234
FI - Finlandia 144
NL - Olanda 144
IE - Irlanda 76
IN - India 74
FR - Francia 54
GB - Regno Unito 51
CA - Canada 46
CI - Costa d'Avorio 35
VN - Vietnam 29
UA - Ucraina 26
ES - Italia 18
AT - Austria 15
IR - Iran 14
ZA - Sudafrica 14
BD - Bangladesh 13
KR - Corea 13
PL - Polonia 12
AR - Argentina 10
MX - Messico 9
IQ - Iraq 8
BE - Belgio 7
TR - Turchia 7
CZ - Repubblica Ceca 6
LT - Lituania 6
UZ - Uzbekistan 6
KE - Kenya 5
RS - Serbia 5
SE - Svezia 5
VE - Venezuela 5
CO - Colombia 4
EG - Egitto 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
JP - Giappone 3
RO - Romania 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
EU - Europa 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
SA - Arabia Saudita 2
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MA - Marocco 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
TW - Taiwan 1
Totale 8.051
Città #
Singapore 682
Hong Kong 464
Moscow 435
Chandler 427
Naples 176
Santa Clara 138
Millbury 137
Ashburn 132
Amsterdam 120
Napoli 120
Munich 110
Des Moines 78
Princeton 71
Beijing 67
Nanjing 62
Boston 54
Lawrence 51
Wilmington 46
Helsinki 41
Kochi 33
Turku 33
Ottawa 30
Rome 29
Frankfurt am Main 28
Hefei 28
Los Angeles 26
Nanchang 24
Milan 22
Hebei 21
São Paulo 21
Falkenstein 20
Seattle 20
San Giovanni Rotondo 19
Dong Ket 16
Nuremberg 16
Jiaxing 13
London 13
Salerno 13
Falls Church 12
New York 12
Redwood City 12
Seoul 12
Dallas 11
Rio de Janeiro 11
Changsha 10
Tehran 10
Tianjin 10
Valencia 10
Warsaw 10
Dublin 9
Shenyang 9
Düsseldorf 8
Lappeenranta 8
Orta di Atella 8
Pune 8
Woodbridge 8
Fairfield 7
Roubaix 7
Santa Maria 7
The Dalles 7
Toronto 7
Verona 7
Viareggio 7
Vienna 7
Belo Horizonte 6
Brooklyn 6
Jacksonville 6
Johannesburg 6
Messina 6
Tashkent 6
Campagna 5
Caserta 5
Chicago 5
Guangzhou 5
Hanoi 5
Houston 5
Lauterbourg 5
Norwalk 5
Pagani 5
Shanghai 5
Atlanta 4
Belgrade 4
Brussels 4
Campinas 4
Chennai 4
Chieti 4
Ho Chi Minh City 4
Montreal 4
Pomigliano d'Arco 4
Portsmouth 4
Redmond 4
Salt Lake City 4
San Francisco 4
Secaucus 4
Villaricca 4
Washington 4
Ardabil 3
Arielli 3
Augusta 3
Baton Rouge 3
Totale 4.232
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 138
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 123
Generation and analysis of spheroids from human primary skin myofibroblasts: an experimental system to study myofibroblasts deactivation 112
Analysis of human primary fibroblast spheroids 108
Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients 104
Thyroid Cancer and Fibroblasts 99
Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone 98
The Metallophosphoesterase-Domain-Containing Protein 2 (MPPED2) Gene Acts as Tumor Suppressor in Breast Cancer 98
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer 97
Discordance in RAS mutations between primary colon tumor and metastases: a real event or a matter of methodology? 93
Development of a Stromal Microenvironment Experimental Model Containing Proto-Myofibroblast Like Cells and Analysis of Its Crosstalk with Melanoma Cells: A New Tool to Potentiate and Stabilize Tumor Suppressor Phenotype of Dermal Myofibroblasts 92
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 90
Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice 87
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives 83
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report 83
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 81
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 80
Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations. 80
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients 79
Foxe1 gene dosage affects thyroid cancer histology and differentiation in vivo 78
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 78
The continuing role of breast fine-needle aspiration biopsy after the introduction of the IAC Yokohama System For Reporting Breast Fine Needle Aspiration Biopsy Cytopathology 77
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 76
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 76
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. 75
Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution 75
Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients 74
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 74
CD10 is useful to identify gastrointestinal contamination in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) cytology from pancreatic ductal adenocarcinoma. 73
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 73
Pure primary squamous cell carcinoma of the breast presenting as an intracystic tumor. 71
Less frequently mutated genes in colorectal cancer: Evidences from next-generation sequencing of 653 routine cases 70
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 70
Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study 69
EGFR mutation detection on lung cancer cytological specimens by the novel fully automated PCR-based Idylla EGFR Mutation Assay 69
Methods for actionable gene fusion detection in lung cancer: now and in the future 68
UbcH10 overexpression in human lung carcinomas and its correlation with EGFR and p53 mutational status. 67
Next-Generation Sequencing of Lung Cancer EGFR Exons 18-21 Allows Effective Molecular Diagnosis of Small Routine Samples (Cytology and Biopsy). 67
Herbal hepatotoxicity: a case of difficult interpretation. 66
Ciliated foregut cyst of the pancreas: A benign lesion with elevated CEA levels 66
UbcH10 overexpression is less pronounced in older colorectal cancer patients 66
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 66
Role of Cytomorphology in the Era of Liquid Biopsy 66
EGFR mutation detection by microfluidic technology: a validation study. 65
Fully automated PCR detection of KRAS mutations on pancreatic endoscopic ultrasound fine-needle aspirates 65
Next generation sequencing in cytology 65
EGFR mutant allelic-specific imbalance assessment in routine samples of non-small cell lung cancer 64
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 64
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 63
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 63
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic 63
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 63
Applications and limitations of oncogene mutation testing in clinical cytopathology. 62
Biopsic Sampling (cancer) comprehensive sampling and sample preparation 61
EGFR analysis: Current evidence and future directions 61
EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: A validation study 61
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 61
SANGER SEQUENCING IN ROUTINE KRAS TESTING: AREVIEW OF 1720 CASES FROM A PATHOLOGIST’SPERSPECTIVE 60
Predictive molecular pathology in the time of COVID-19 60
PD-L1 and beyond: Immuno-oncology in cytopathology 60
How should a follicular adenoma with papillary architecture be classified on thyroid FNA? Case report with histological correlation 59
Bird's eye view of modern cytopathology: Report from the seventh international Molecular Cytopathology Meeting in Naples, Italy, 2018 59
KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test 59
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 58
KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs, and beyond 58
Potential involvement of neutrophils in human thyroid cancer 58
Cytological and Molecular Features of PapillaryThyroid Carcinoma with Prominent Hobnail Features:A Case Report 57
Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens 57
Brca1/2 ngs somatic testing in clinical practice: a short report 57
KRAS mutation detection by high resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer 56
KRAS Mutant Allele Specific Imbalance (MASI) assessment in routine samples of metastatic colorectal cancer patients 56
Microfluidic chip technology applied to fine-needle aspiration cytology samples for IGH clonality assessment 56
Cytologically undetermined follicular lesions: surgical procedures and histological outcome in 472 cases. 55
Impact assessment of the implementation of an integrated care model for thyroid disease at the university hospital “federico ii” of naples (Campania region, southern italy): An interrupted time series analysis 55
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study 55
Challenges and opportunities of next-generation sequencing: a cytopathologist's perspective 54
Cytopathologists can reliably perform ultrasound-guided thyroid fine needle aspiration: a 1-year audit on 3715 consecutive cases 54
Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples? 54
There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression 54
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 54
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 53
EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: A case report and literature review 52
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 52
Interobserver variability in cytopathology: How much do we agree? 51
Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens 51
How to prepare cytological samples for molecular testing 51
Multiple predictive biomarker testing in melanoma: another challenge for the optimal approach on cytological samples 50
The evolving role of interventional cytopathology from thyroid FNA to NGS: Lessons learned at Federico II University of Naples 50
Multicentric encapsulated papillary oncocytic neoplasm of the thyroid: A case diagnosed by a combined cytological, histological, immunohistochemical, and molecular approach 50
Kras Testing On Cytologic Imprints of Colo-rectal Carcinoma 50
Foamy gland pancreatic ductal adenocarcinoma diagnosed on EUS-FNA: A histochemical, immunohistochemical, and molecular report 50
In Vivo Histological Assessment of a Spontaneous Coronary Artery Dissection 49
UbcH10 may be a useful tool in the prognosis of lung carcinomas 49
Outsourcing cytological samples to a referral laboratory for EGFR testing in non-small cell lung cancer: does theory meet practice? 49
Is the Isthmus Location an Additional Risk Factor for Indeterminate Thyroid Nodules? Case Report and Review of the Literature. 49
A novel approach to classification and reporting of lymph node fine-needle cytology: Application of the proposed sydney system 49
Tissue Microarray from Cell Block Material (cbTMA)—An Additional Shot for Cytology in the Predictive Pathology Era: The PD-L1 Experience 49
PAX8 is expressed in anaplastic thyroid carcinoma diagnosed by fine-needle aspiration: a study of three cases with histological correlates. 48
EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study 47
Epidermal Growth Factor Receptor Test Performed on Liquid-Based Cytology Lung Samples: Experience of an Academic Referral Center. 47
Totale 6.717
Categoria #
all - tutte 34.662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.662


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021207 8 1 8 8 9 44 18 24 32 24 12 19
2021/2022754 12 13 8 11 9 16 14 43 78 63 172 315
2022/20231.101 131 56 41 83 142 118 5 118 201 123 65 18
2023/2024730 39 137 91 48 30 50 6 88 23 33 106 79
2024/20254.420 199 235 8 23 114 213 437 272 284 560 1.706 369
2025/2026269 269 0 0 0 0 0 0 0 0 0 0 0
Totale 8.349